Literature DB >> 23833237

Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human Vγ2Vδ2 T cells.

Hong Wang1, Olivier Henry, Mark D Distefano, Yen-Chih Wang, Johanna Räikkönen, Jukka Mönkkönen, Yoshimasa Tanaka, Craig T Morita.   

Abstract

Most human γδ T cells express Vγ2Vδ2 TCRs and play important roles in microbial and tumor immunity. Vγ2Vδ2 T cells are stimulated by self- and foreign prenyl pyrophosphate intermediates in isoprenoid synthesis. However, little is known about the molecular basis for this stimulation. We find that a mAb specific for butyrophilin 3 (BTN3)/CD277 Ig superfamily proteins mimics prenyl pyrophosphates. The 20.1 mAb stimulated Vγ2Vδ2 T cell clones regardless of their functional phenotype or developmental origin and selectively expanded blood Vγ2Vδ2 T cells. The γδ TCR mediates 20.1 mAb stimulation because IL-2 is released by β(-) Jurkat cells transfected with Vγ2Vδ2 TCRs. 20.1 stimulation was not due to isopentenyl pyrophosphate (IPP) accumulation because 20.1 treatment of APC did not increase IPP levels. In addition, stimulation was not inhibited by statin treatment, which blocks IPP production. Importantly, small interfering RNA knockdown of BTN3A1 abolished stimulation by IPP that could be restored by re-expression of BTN3A1 but not by BTN3A2 or BTN3A3. Rhesus monkey and baboon APC presented HMBPP and 20.1 to human Vγ2Vδ2 T cells despite amino acid differences in BTN3A1 that localize to its outer surface. This suggests that the conserved inner and/or top surfaces of BTN3A1 interact with its counterreceptor. Although no binding site exists on the BTN3A1 extracellular domains, a model of the intracellular B30.2 domain predicts a basic pocket on its binding surface. However, BTN3A1 did not preferentially bind a photoaffinity prenyl pyrophosphate. Thus, BTN3A1 is required for stimulation by prenyl pyrophosphates but does not bind the intermediates with high affinity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23833237      PMCID: PMC3884521          DOI: 10.4049/jimmunol.1300658

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  78 in total

1.  Frontline: Characterization of BT3 molecules belonging to the B7 family expressed on immune cells.

Authors:  Elsa Compte; Pierre Pontarotti; Yves Collette; Marc Lopez; Daniel Olive
Journal:  Eur J Immunol       Date:  2004-08       Impact factor: 5.532

2.  Functionally distinct subsets of human gamma/delta T cells.

Authors:  C T Morita; S Verma; P Aparicio; C Martinez; H Spits; M B Brenner
Journal:  Eur J Immunol       Date:  1991-12       Impact factor: 5.532

3.  Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412.

Authors:  Ganesh Suntharalingam; Meghan R Perry; Stephen Ward; Stephen J Brett; Andrew Castello-Cortes; Michael D Brunner; Nicki Panoskaltsis
Journal:  N Engl J Med       Date:  2006-08-14       Impact factor: 91.245

4.  Activation of T cells by carbamazepine and carbamazepine metabolites.

Authors:  Ying Wu; Joseph P Sanderson; John Farrell; Nicola S Drummond; Anita Hanson; Elizabeth Bowkett; Neil Berry; Andrew V Stachulski; Stephen E Clarke; Werner J Pichler; Munir Pirmohamed; B Kevin Park; Dean J Naisbitt
Journal:  J Allergy Clin Immunol       Date:  2006-04-27       Impact factor: 10.793

Review 5.  Pharmacological interaction of drugs with immune receptors: the p-i concept.

Authors:  Werner J Pichler; Andreas Beeler; Monika Keller; Marianne Lerch; Sinforiano Posadas; Daphné Schmid; Zoi Spanou; Anna Zawodniak; Basil Gerber
Journal:  Allergol Int       Date:  2006-03       Impact factor: 5.836

6.  T-cell receptor gamma/delta: comparison of gene configurations and function between humans and chimpanzees.

Authors:  E Sturm; R E Bontrop; R J Vreugdenhil; N Otting; R L Bolhuis
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

7.  Quantitative structure-activity relationships for gammadelta T cell activation by bisphosphonates.

Authors:  John M Sanders; Subhash Ghosh; Julian M W Chan; Gary Meints; Hong Wang; Amy M Raker; Yongcheng Song; Alison Colantino; Agnieszka Burzynska; Pawel Kafarski; Craig T Morita; Eric Oldfield
Journal:  J Med Chem       Date:  2004-01-15       Impact factor: 7.446

8.  Statins prevent bisphosphonate-induced gamma,delta-T-cell proliferation and activation in vitro.

Authors:  Keith Thompson; Michael J Rogers
Journal:  J Bone Miner Res       Date:  2003-12-16       Impact factor: 6.741

9.  Functional and phenotypic differences between CD4+ and CD4- T cell receptor-gamma delta clones from peripheral blood.

Authors:  H Spits; X Paliard; Y Vandekerckhove; P van Vlasselaer; J E de Vries
Journal:  J Immunol       Date:  1991-08-15       Impact factor: 5.422

10.  All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction.

Authors:  Sadayuki Ohkura; Melvyn W Yap; Tom Sheldon; Jonathan P Stoye
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

View more
  86 in total

1.  Zoledronate can induce colorectal cancer microenvironment expressing BTN3A1 to stimulate effector γδ T cells with antitumor activity.

Authors:  Maria Raffaella Zocchi; Delfina Costa; Roberta Venè; Francesca Tosetti; Nicoletta Ferrari; Simona Minghelli; Roberto Benelli; Stefano Scabini; Emanuele Romairone; Silvia Catellani; Aldo Profumo; Alessandro Poggi
Journal:  Oncoimmunology       Date:  2017-01-06       Impact factor: 8.110

2.  Critical Roles for Coiled-Coil Dimers of Butyrophilin 3A1 in the Sensing of Prenyl Pyrophosphates by Human Vγ2Vδ2 T Cells.

Authors:  Hong Wang; Mohanad H Nada; Yoshimasa Tanaka; Shun Sakuraba; Craig T Morita
Journal:  J Immunol       Date:  2019-06-21       Impact factor: 5.422

3.  A fat story-antigen presentation by butyrophilin 3A1 to γδ T cells.

Authors:  Charlotte Esser
Journal:  Cell Mol Immunol       Date:  2013-10-07       Impact factor: 11.530

4.  Critical role of butyrophilin 3A1 in presenting prenyl pyrophosphate antigens to human γδ T cells.

Authors:  Dieter Kabelitz
Journal:  Cell Mol Immunol       Date:  2013-10-07       Impact factor: 11.530

5.  Butyrophilin 3A1 presents phosphoantigens to human γδ T cells: the fourth model of antigen presentation in the immune system.

Authors:  Francesco Dieli; Raffaela Fadda; Nadia Caccamo
Journal:  Cell Mol Immunol       Date:  2013-11-25       Impact factor: 11.530

Review 6.  The immune response to malaria in utero.

Authors:  Margaret E Feeney
Journal:  Immunol Rev       Date:  2019-09-25       Impact factor: 12.988

7.  HMBPP Analog Prodrugs Bypass Energy-Dependent Uptake To Promote Efficient BTN3A1-Mediated Malignant Cell Lysis by Vγ9Vδ2 T Lymphocyte Effectors.

Authors:  Ashley M Kilcollins; Jin Li; Chia-Hung Christine Hsiao; Andrew J Wiemer
Journal:  J Immunol       Date:  2016-06-06       Impact factor: 5.422

8.  Low dose gemcitabine increases the cytotoxicity of human Vγ9Vδ2 T cells in bladder cancer cells in vitro and in an orthotopic xenograft model.

Authors:  Teruki Shimizu; Mako Tomogane; Masatsugu Miyashita; Osamu Ukimura; Eishi Ashihara
Journal:  Oncoimmunology       Date:  2018-02-08       Impact factor: 8.110

9.  Vγ9 and Vδ2 T cell antigen receptor genes and butyrophilin 3 (BTN3) emerged with placental mammals and are concomitantly preserved in selected species like alpaca (Vicugna pacos).

Authors:  Mohindar M Karunakaran; Thomas W Göbel; Lisa Starick; Lutz Walter; Thomas Herrmann
Journal:  Immunogenetics       Date:  2014-02-14       Impact factor: 2.846

Review 10.  Evolution and function of the TCR Vgamma9 chain repertoire: It's good to be public.

Authors:  C David Pauza; Cristiana Cairo
Journal:  Cell Immunol       Date:  2015-03-04       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.